Aditxt, Inc. (ADTX)
USD 2.23
(3.72%)
USD 2.23
(3.72%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -4326.64 USD | 82.39% |
| 2022 | -608.04 USD | 87.99% |
| 2021 | -5061.14 USD | -247.07% |
| 2020 | -1458.23 USD | 35.31% |
| 2019 | -2254.10 USD | 22.19% |
| 2018 | -2896.76 USD | -3417.62% |
| 2017 | -82.35 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -9.14 USD | 38.62% |
| 2024 Q2 | -4.19 USD | 54.16% |
| 2023 Q2 | -36.79 USD | 34.28% |
| 2023 Q3 | -47.95 USD | -30.33% |
| 2023 Q1 | -55.98 USD | 30.96% |
| 2023 FY | - USD | 82.39% |
| 2023 Q4 | -14.89 USD | 68.95% |
| 2022 Q4 | -81.08 USD | 70.12% |
| 2022 Q3 | -271.37 USD | -5.67% |
| 2022 Q2 | -256.80 USD | 4.62% |
| 2022 FY | - USD | 87.99% |
| 2022 Q1 | -269.24 USD | 75.13% |
| 2021 FY | - USD | -247.07% |
| 2021 Q4 | -1082.76 USD | 3.6% |
| 2021 Q3 | -1123.21 USD | -32.37% |
| 2021 Q2 | -848.57 USD | 8.04% |
| 2021 Q1 | -922.72 USD | -27.85% |
| 2020 Q1 | -450.69 USD | 10.69% |
| 2020 Q2 | -272.06 USD | 39.63% |
| 2020 Q4 | -721.73 USD | 2.2% |
| 2020 FY | - USD | 35.31% |
| 2020 Q3 | -737.95 USD | -171.25% |
| 2019 Q1 | -464.14 USD | -81.98% |
| 2019 Q4 | -504.63 USD | 8.27% |
| 2019 FY | - USD | 22.19% |
| 2019 Q3 | -550.10 USD | 57.73% |
| 2019 Q2 | -1301.41 USD | -180.39% |
| 2018 Q2 | - USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2018 FY | - USD | -3417.62% |
| 2018 Q4 | -255.05 USD | 0.0% |
| 2018 Q1 | - USD | 100.0% |
| 2017 FY | - USD | 0.0% |
| 2017 Q4 | -108.45 USD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Absci Corporation | -1.20 USD | -360453.333% |
| Adaptive Biotechnologies Corporation | -1.56 USD | -277248.718% |
| Alnylam Pharmaceuticals, Inc. | -3.52 USD | -122815.909% |
| Alzamend Neuro, Inc. | -14.72 USD | -29292.935% |
| Apollomics, Inc. | -2.32 USD | -186393.103% |
| 180 Life Sciences Corp. | -52.60 USD | -8125.551% |
| Atossa Therapeutics, Inc. | -0.24 USD | -1802666.667% |
| Bicycle Therapeutics plc | -5.08 USD | -85070.079% |
| Barinthus Biotherapeutics plc | -1.91 USD | -226425.654% |
| BioXcel Therapeutics, Inc. | -6.15 USD | -70251.87% |
| CASI Pharmaceuticals, Inc. | -2.02 USD | -214090.099% |
| Chimerix, Inc. | -0.93 USD | -465130.108% |
| CRISPR Therapeutics AG | -1.94 USD | -222922.68% |
| Contineum Therapeutics, Inc. Class A Common Stock | 1.36 USD | 318235.294% |
| EyePoint Pharmaceuticals, Inc. | -1.82 USD | -237627.473% |
| Fortress Biotech, Inc. | -8.47 USD | -50981.936% |
| Fortress Biotech, Inc. | -8.47 USD | -50981.936% |
| Gritstone bio, Inc. | -1.20 USD | -360453.333% |
| Allakos Inc. | -2.14 USD | -202079.439% |
| Boundless Bio, Inc. Common Stock | -2.22 USD | -194793.694% |
| Cara Therapeutics, Inc. | -2.19 USD | -197463.47% |
| Cytokinetics, Incorporated | -5.45 USD | -79287.89% |
| enGene Holdings Inc. Common Stock | -4.51 USD | -95834.368% |
| Innoviva, Inc. | 2.92 USD | 148272.603% |
| Hoth Therapeutics, Inc. | -2.30 USD | -188014.783% |
| NLS Pharmaceutics AG | -0.32 USD | -1351975.0% |
| RAPT Therapeutics, Inc. | -3.05 USD | -141757.049% |
| Salarius Pharmaceuticals, Inc. | -0.00 USD | -113858847.368% |
| Terns Pharmaceuticals, Inc. | -1.27 USD | -340580.315% |
| Vigil Neuroscience, Inc. | -2.13 USD | -203028.638% |
| ImmuCell Corporation | -0.75 USD | -576785.333% |
| IDEAYA Biosciences, Inc. | -1.96 USD | -220646.939% |
| Incyte Corporation | 2.67 USD | 162146.442% |
| Inovio Pharmaceuticals, Inc. | -6.09 USD | -70944.992% |
| Lexaria Bioscience Corp. | -1.01 USD | -428280.198% |
| Mustang Bio, Inc. | -6.00 USD | -72010.667% |
| MiMedx Group, Inc. | 0.48 USD | 901483.333% |
| MEI Pharma, Inc. | 2.67 USD | 162146.442% |
| MacroGenics, Inc. | -0.15 USD | -2884326.667% |
| Monopar Therapeutics Inc. | -0.58 USD | -745872.414% |
| Mereo BioPharma Group plc | -0.04 USD | -9679184.116% |
| Marker Therapeutics, Inc. | -1.93 USD | -224078.238% |
| Marinus Pharmaceuticals, Inc. | -2.63 USD | -164411.027% |
| Maravai LifeSciences Holdings, Inc. | -0.90 USD | -480637.778% |
| Minerva Neurosciences, Inc. | -4.61 USD | -93753.362% |
| NeuroBo Pharmaceuticals, Inc. | -2.46 USD | -175779.675% |
| NeuroSense Therapeutics Ltd. | -0.83 USD | -521181.928% |
| NextCure, Inc. | -2.25 USD | -192195.111% |
| Orchestra BioMed Holdings, Inc. | -1.48 USD | -292240.541% |
| Ocuphire Pharma, Inc. | -0.46 USD | -940473.913% |
| Onconetix, Inc. | -2.19 USD | -197463.47% |
| Oncternal Therapeutics, Inc. | -13.43 USD | -32116.232% |
| Opthea Limited | -0.35 USD | -1236082.857% |
| Ovid Therapeutics Inc. | -0.74 USD | -584581.081% |
| Psyence Biomedical Ltd. | -7.85 USD | -55016.433% |
| PDS Biotechnology Corporation | -1.39 USD | -311169.065% |
| Precigen, Inc. | -0.39 USD | -1109294.872% |
| Pieris Pharmaceuticals, Inc. | -21.80 USD | -19746.972% |
| Prime Medicine, Inc. | -2.18 USD | -198369.725% |
| PureTech Health plc | -2.38 USD | -181691.597% |
| Rocket Pharmaceuticals, Inc. | -2.92 USD | -148072.603% |
| Regeneron Pharmaceuticals, Inc. | 37.05 USD | 11777.841% |
| Replimune Group, Inc. | -3.24 USD | -133438.272% |
| Revelation Biosciences, Inc. | -0.53 USD | -816247.17% |
| Rigel Pharmaceuticals, Inc. | -1.44 USD | -300361.111% |
| TransCode Therapeutics, Inc. | -103.61 USD | -4075.89% |
| Revolution Medicines, Inc. Warrant | -3.86 USD | -111989.119% |
| Reviva Pharmaceuticals Holdings, Inc. | -1.25 USD | -346031.2% |
| Sesen Bio, Inc. | -1.99 USD | -217319.095% |
| Sangamo Therapeutics, Inc. | -1.48 USD | -292240.541% |
| Solid Biosciences Inc. | -4.83 USD | -89478.468% |
| Syndax Pharmaceuticals, Inc. | -2.98 USD | -145089.262% |
| SciSparc Ltd. | -14.43 USD | -29883.645% |
| Sutro Biopharma, Inc. | -1.78 USD | -242969.663% |
| TG Therapeutics, Inc. | 0.09 USD | 4845161.59% |
| Tonix Pharmaceuticals Holding Corp. | -219.09 USD | -1874.823% |
| Titan Pharmaceuticals, Inc. | -7.41 USD | -58289.204% |
| Travere Therapeutics, Inc. | -1.50 USD | -288342.667% |
| UroGen Pharma Ltd. | -3.55 USD | -121777.183% |
| Verrica Pharmaceuticals Inc. | -1.48 USD | -292240.541% |
| XOMA Corporation | -4.04 USD | -106995.05% |
| Zentalis Pharmaceuticals, Inc. | -4.47 USD | -96692.841% |
| AbCellera Biologics Inc. | -0.51 USD | -848260.784% |
| Longboard Pharmaceuticals, Inc. | -2.39 USD | -180930.962% |
| Cassava Sciences, Inc. | -2.32 USD | -186393.103% |
| Corbus Pharmaceuticals Holdings, Inc. | -10.31 USD | -41865.47% |
| Precision BioSciences, Inc. | -15.96 USD | -27009.273% |
| Dyadic International, Inc. | -0.24 USD | -1802666.667% |
| Intensity Therapeutics, Inc. | -1.38 USD | -313424.638% |
| Eton Pharmaceuticals, Inc. | -0.04 USD | -11853708.219% |
| VYNE Therapeutics Inc. | -2.77 USD | -156096.39% |
| Tenaya Therapeutics, Inc. | -1.68 USD | -257438.095% |
| IGM Biosciences, Inc. | -4.71 USD | -91760.722% |
| X4 Pharmaceuticals, Inc. | -0.57 USD | -758959.649% |
| Acelyrin, Inc. | -5.43 USD | -79580.295% |
| Abeona Therapeutics Inc. | -2.53 USD | -170913.439% |
| Ligand Pharmaceuticals Incorporated | 3.02 USD | 143366.225% |
| Inhibikase Therapeutics, Inc. | -3.57 USD | -121094.398% |
| Arcturus Therapeutics Holdings Inc. | -1.12 USD | -386207.143% |
| Syros Pharmaceuticals, Inc. | -5.81 USD | -74368.847% |
| Senti Biosciences, Inc. | -16.01 USD | -26924.61% |
| Mesoblast Limited | -0.89 USD | -486039.326% |
| Kymera Therapeutics, Inc. | -2.52 USD | -171592.063% |
| ChromaDex Corporation | -0.07 USD | -6565362.822% |
| BriaCell Therapeutics Corp. | -0.29 USD | -1491844.828% |
| Akebia Therapeutics, Inc. | -0.28 USD | -1545128.571% |
| Dermata Therapeutics, Inc. | -40.18 USD | -10668.143% |
| Seer, Inc. | -1.35 USD | -320391.852% |
| Xeris Biopharma Holdings, Inc. | -0.45 USD | -961375.556% |
| Novavax, Inc. | -5.41 USD | -79874.861% |
| Virpax Pharmaceuticals, Inc. | -12.97 USD | -33258.828% |
| Fate Therapeutics, Inc. | -1.64 USD | -263719.512% |
| Checkpoint Therapeutics, Inc. | -2.77 USD | -156096.39% |
| Lyell Immunopharma, Inc. | -0.93 USD | -465130.108% |
| Celcuity Inc. | -2.69 USD | -160741.636% |
| ContextLogic Inc. | -13.36 USD | -32285.03% |
| Phathom Pharmaceuticals, Inc. | -3.93 USD | -109992.621% |
| HOOKIPA Pharma Inc. | -8.63 USD | -50034.878% |
| Jazz Pharmaceuticals plc | 6.95 USD | 62353.813% |
| Amarin Corporation plc | -0.15 USD | -2884326.667% |
| AnaptysBio, Inc. | -6.08 USD | -71061.842% |
| Aptevo Therapeutics Inc. | -62.62 USD | -6809.358% |
| Aptorum Group Limited | -0.62 USD | -697745.161% |
| Cartesian Therapeutics, Inc. | -42.49 USD | -10082.725% |
| Arrowhead Pharmaceuticals, Inc. | -1.91 USD | -226425.654% |
| Ardelyx, Inc. | -0.30 USD | -1442113.333% |
| Celularity Inc. | -11.02 USD | -39161.706% |
| Omeros Corporation | -1.88 USD | -230040.426% |
| Humacyte, Inc. | -1.07 USD | -404258.879% |
| Immunocore Holdings plc | -1.13 USD | -382788.496% |
| IO Biotech, Inc. | -1.98 USD | -218417.172% |
| GT Biopharma, Inc. | -5.64 USD | -76613.475% |
| Cabaletta Bio, Inc. | -1.65 USD | -262120.606% |
| Summit Therapeutics Inc. | -0.99 USD | -436934.343% |
| Alaunos Therapeutics, Inc. | -21.97 USD | -19593.4% |
| Pulmatrix, Inc. | -3.87 USD | -111699.483% |
| Intellia Therapeutics, Inc. | -5.42 USD | -79727.306% |
| Evogene Ltd. | -5.23 USD | -82627.342% |
| CorMedix Inc. | -0.91 USD | -475354.945% |
| BioLineRx Ltd. | -0.94 USD | -460180.851% |
| VistaGen Therapeutics, Inc. | -1.52 USD | -284547.368% |
| Sagimet Biosciences Inc. | -2.66 USD | -162555.639% |
| PTC Therapeutics, Inc. | -8.37 USD | -51592.234% |
| scPharmaceuticals Inc. | -1.42 USD | -304592.958% |
| Fulcrum Therapeutics, Inc. | -1.59 USD | -272015.723% |
| Corcept Therapeutics Incorporated | 1.02 USD | 424280.392% |
| NLS Pharmaceutics AG | -0.32 USD | -1351975.0% |
| Reviva Pharmaceuticals Holdings, Inc. | -1.25 USD | -346031.2% |
| Akero Therapeutics, Inc. | -2.89 USD | -149610.727% |
| Eliem Therapeutics, Inc. | -1.30 USD | -332718.462% |
| Lisata Therapeutics, Inc. | -2.58 USD | -167599.225% |
| Stoke Therapeutics, Inc. | -2.38 USD | -181691.597% |
| Reneo Pharmaceuticals, Inc. | -25.23 USD | -17048.791% |
| Outlook Therapeutics, Inc. | -4.72 USD | -91566.102% |
| ProMIS Neurosciences, Inc. | -1.42 USD | -304592.958% |
| Daré Bioscience, Inc. | -4.15 USD | -104156.386% |
| bluebird bio, Inc. | -1.93 USD | -224078.238% |
| BioMarin Pharmaceutical Inc. | 0.89 USD | 486239.326% |
| DBV Technologies S.A. | -0.76 USD | -569194.737% |
| Avidity Biosciences, Inc. | -2.91 USD | -148581.787% |
| Galecto, Inc. | -36.08 USD | -11891.796% |
| Sensei Biotherapeutics, Inc. | -1.22 USD | -354542.623% |
| Spruce Biosciences, Inc. | -1.24 USD | -348822.581% |
| Inhibrx Biosciences, Inc. | -5.12 USD | -84404.688% |
| GlycoMimetics, Inc. | -0.58 USD | -745872.414% |
| Arcutis Biotherapeutics, Inc. | -3.78 USD | -114361.376% |
| ADMA Biologics, Inc. | -0.13 USD | -3328084.615% |
| Clene Inc. | -9.43 USD | -45781.654% |
| Recursion Pharmaceuticals, Inc. | -1.58 USD | -273737.975% |
| Aptose Biosciences Inc. | -7.58 USD | -56979.683% |
| ZyVersa Therapeutics, Inc. | -1089.67 USD | -297.06% |
| Soligenix, Inc. | -12.66 USD | -34075.671% |
| Century Therapeutics, Inc. | -2.30 USD | -188014.783% |
| Kura Oncology, Inc. | -2.08 USD | -207911.538% |
| Surrozen, Inc. | -21.33 USD | -20184.294% |
| TScan Therapeutics, Inc. | -1.36 USD | -318035.294% |
| Ocean Biomedical, Inc. | -0.03 USD | -16451002.662% |
| CytomX Therapeutics, Inc. | -0.01 USD | -56190029.87% |
| Autolus Therapeutics plc | -1.20 USD | -360453.333% |
| Mineralys Therapeutics, Inc. | -1.99 USD | -217319.095% |
| Eterna Therapeutics Inc. | -4.08 USD | -105945.098% |
| Caribou Biosciences, Inc. | -1.38 USD | -313424.638% |
| GRI Bio, Inc. | -28.25 USD | -15215.54% |
| Xenetic Biosciences, Inc. | -2.71 USD | -159554.613% |
| Janux Therapeutics, Inc. | -1.32 USD | -327675.758% |
| INmune Bio, Inc. | -1.67 USD | -258980.24% |
| Heron Therapeutics, Inc. | -0.80 USD | -540730.0% |
| SAB Biotherapeutics, Inc. | -7.64 USD | -56531.414% |
| Pasithea Therapeutics Corp. | -12.65 USD | -34102.688% |
| Tenax Therapeutics, Inc. | -31.09 USD | -13816.5% |
| Jaguar Health, Inc. | -107.42 USD | -3927.779% |
| Entero Therapeutics, Inc. | -47.88 USD | -8936.424% |
| Milestone Pharmaceuticals Inc. | -1.39 USD | -311169.065% |
| Clearside Biomedical, Inc. | -0.53 USD | -816247.17% |
| Atara Biotherapeutics, Inc. | -65.18 USD | -6537.987% |
| Coherus BioSciences, Inc. | -2.53 USD | -170913.439% |
| Verastem, Inc. | -3.96 USD | -109158.586% |
| Pliant Therapeutics, Inc. | -2.75 USD | -157232.364% |
| Histogen Inc. | -3.46 USD | -124947.399% |
| Aprea Therapeutics, Inc. | -3.95 USD | -109435.19% |
| ACADIA Pharmaceuticals Inc. | -0.37 USD | -1169262.162% |
| Surrozen, Inc. | -21.33 USD | -20184.294% |
| Organovo Holdings, Inc. | -1.60 USD | -270315.0% |
| Lixte Biotechnology Holdings, Inc. | -2.66 USD | -162555.639% |
| Cadrenal Therapeutics, Inc. Common Stock | -0.62 USD | -697745.161% |
| Centessa Pharmaceuticals plc | -1.57 USD | -275482.166% |
| Hepion Pharmaceuticals, Inc. | -12.32 USD | -35018.831% |
| BioRestorative Therapies, Inc. | -2.47 USD | -175067.611% |
| Kronos Bio, Inc. | -1.95 USD | -221778.974% |
| Turnstone Biologics Corp. | -4.77 USD | -90605.241% |
| Synaptogenix, Inc. | -29.56 USD | -14536.806% |
| Tiziana Life Sciences Ltd | -0.16 USD | -2704050.0% |
| Entrada Therapeutics, Inc. | -0.20 USD | -2163220.0% |
| Aurinia Pharmaceuticals Inc. | -0.54 USD | -801129.63% |
| Exelixis, Inc. | 0.65 USD | 665736.923% |
| Nurix Therapeutics, Inc. | -2.65 USD | -163169.434% |
| Apellis Pharmaceuticals, Inc. | -4.45 USD | -97127.865% |
| Jasper Therapeutics, Inc. | -6.18 USD | -69910.356% |
| ESSA Pharma Inc. | -0.60 USD | -721006.667% |
| TNF Pharmaceuticals, Inc. | -5.33 USD | -81075.235% |
| Avid Bioservices, Inc. | -2.23 USD | -193919.731% |
| Insmed Incorporated | -5.34 USD | -80923.221% |
| MediWound Ltd. | -0.75 USD | -576785.333% |
| OmniAb, Inc. | -0.51 USD | -848260.784% |
| Alector, Inc. | -1.56 USD | -277248.718% |
| Seres Therapeutics, Inc. | -0.89 USD | -486039.326% |
| Zai Lab Limited | -3.46 USD | -124947.399% |
| AlloVir, Inc. | -1.83 USD | -236328.415% |
| Revance Therapeutics, Inc. | -3.83 USD | -112867.102% |
| ORIC Pharmaceuticals, Inc. | -1.96 USD | -220646.939% |
| Aura Biosciences, Inc. | -1.93 USD | -224078.238% |
| Immunic, Inc. | -2.11 USD | -204954.028% |
| Tarsus Pharmaceuticals, Inc. | -4.62 USD | -93550.216% |
| Veracyte, Inc. | -1.02 USD | -424080.392% |
| InMed Pharmaceuticals Inc. | -1.01 USD | -428280.198% |
| FibroGen, Inc. | -2.92 USD | -148072.603% |
| SeaStar Medical Holding Corporation | -30.29 USD | -14184.054% |
| Catalyst Pharmaceuticals, Inc. | 0.67 USD | 645867.164% |
| Adial Pharmaceuticals, Inc. | -5.44 USD | -79433.824% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.14 USD | -23751.378% |
| Cyclacel Pharmaceuticals, Inc. | -26.75 USD | -16074.355% |
| Amylyx Pharmaceuticals, Inc. | 0.73 USD | 592790.411% |
| Fortrea Holdings Inc. | -0.04 USD | -11296610.183% |
| KalVista Pharmaceuticals, Inc. | -3.44 USD | -125674.419% |
| XBiotech Inc. | -0.81 USD | -534053.086% |
| Jasper Therapeutics, Inc. | -6.18 USD | -69910.356% |
| Keros Therapeutics, Inc. | -5.20 USD | -83104.615% |
| SELLAS Life Sciences Group, Inc. | -1.34 USD | -322783.582% |
| Lyra Therapeutics, Inc. | -1.26 USD | -343284.127% |
| Foghorn Therapeutics Inc. | -2.34 USD | -184799.145% |
| Agenus Inc. | -13.75 USD | -31366.473% |
| Y-mAbs Therapeutics, Inc. | -0.49 USD | -882887.755% |
| Theravance Biopharma, Inc. | -1.00 USD | -432564.0% |
| Ultragenyx Pharmaceutical Inc. | -8.25 USD | -52344.121% |
| Metagenomi, Inc. Common Stock | -1.82 USD | -237627.473% |
| BioCryst Pharmaceuticals, Inc. | -1.18 USD | -366564.407% |
| Gain Therapeutics, Inc. | -1.71 USD | -252919.883% |
| C4 Therapeutics, Inc. | -2.67 USD | -161946.442% |
| Creative Medical Technology Holdings, Inc. | -3.76 USD | -114970.213% |
| Chemomab Therapeutics Ltd. | -2.06 USD | -209931.068% |
| Lantern Pharma Inc. | -1.47 USD | -294229.252% |
| Eledon Pharmaceuticals, Inc. | -0.00 USD | -270414900.0% |
| Ainos, Inc. | -3.36 USD | -128669.048% |
| Pluri Inc. | -3.99 USD | -108337.093% |
| Prothena Corporation plc | -2.76 USD | -156662.319% |
| Adaptimmune Therapeutics plc | -0.57 USD | -758959.649% |
| Rallybio Corporation | -1.84 USD | -235043.478% |
| Kodiak Sciences Inc. | -4.97 USD | -86955.131% |
| Cue Biopharma, Inc. | -1.11 USD | -389687.387% |
| MeiraGTx Holdings plc | -1.49 USD | -290278.523% |
| Annexon, Inc. | -1.77 USD | -244342.938% |
| Assembly Biosciences, Inc. | -13.38 USD | -32236.622% |
| Moderna, Inc. | -12.34 USD | -34961.912% |
| Cocrystal Pharma, Inc. | -1.86 USD | -232515.054% |
| Cidara Therapeutics, Inc. | -5.25 USD | -82312.19% |
| Blueprint Medicines Corporation | -8.37 USD | -51592.234% |
| Immix Biopharma, Inc. | -0.89 USD | -486039.326% |
| CalciMedica, Inc. | -7.65 USD | -56457.386% |
| Monte Rosa Therapeutics, Inc. | -2.63 USD | -164411.027% |
| Scholar Rock Holding Corporation | -1.99 USD | -217319.095% |
| Wave Life Sciences Ltd. | -0.54 USD | -801129.63% |
| Sana Biotechnology, Inc. | -1.46 USD | -296245.205% |
| Elicio Therapeutics, Inc. | -6.96 USD | -62064.368% |
| Adlai Nortye Ltd. American Depositary Shares | -7.26 USD | -59495.592% |
| Nutriband Inc. | -0.69 USD | -626949.275% |
| Protara Therapeutics, Inc. | -3.57 USD | -121094.398% |
| Vor Biopharma Inc. | -1.75 USD | -247136.571% |
| Roivant Sciences Ltd. | 5.55 USD | 78057.477% |
| Alkermes plc | 2.14 USD | 202279.439% |
| ProKidney Corp. | -0.57 USD | -758959.649% |
| Applied Therapeutics, Inc. | -1.42 USD | -304592.958% |
| Arcellx, Inc. | -1.47 USD | -294229.252% |
| BridgeBio Pharma, Inc. | -3.95 USD | -109435.19% |
| Tango Therapeutics, Inc. | -1.08 USD | -400514.815% |
| Galectin Therapeutics Inc. | -0.74 USD | -584581.081% |
| Atai Life Sciences N.V. | -0.25 USD | -1730556.0% |
| Renovaro Biosciences Inc. | -0.84 USD | -514976.19% |
| Aerovate Therapeutics, Inc. | -2.87 USD | -150654.007% |
| MediciNova, Inc. | -0.17 USD | -2544982.353% |
| Praxis Precision Medicines, Inc. | -18.69 USD | -23049.492% |
| Cardio Diagnostics Holdings, Inc. | -0.66 USD | -655451.515% |
| GeoVax Labs, Inc. | -10.22 USD | -42235.029% |
| Axsome Therapeutics, Inc. | -5.27 USD | -81999.431% |
| Biomea Fusion, Inc. | -3.44 USD | -125674.419% |
| RenovoRx, Inc. | -0.99 USD | -436934.343% |
| Cullinan Oncology, Inc. | -3.69 USD | -117153.117% |
| Geron Corporation | -0.32 USD | -1351975.0% |
| NRx Pharmaceuticals, Inc. | -3.98 USD | -108609.548% |
| 4D Molecular Therapeutics, Inc. | -2.58 USD | -167599.225% |
| Dyne Therapeutics, Inc. | -3.95 USD | -109435.19% |
| Kiniksa Pharmaceuticals, Ltd. | 0.20 USD | 2163420.0% |
| Royalty Pharma plc | 3.41 USD | 126980.938% |
| Ventyx Biosciences, Inc. | -3.30 USD | -131010.303% |
| Imunon, Inc. | -2.16 USD | -200207.407% |
| BioAtla, Inc. | -2.58 USD | -167599.225% |
| Allogene Therapeutics, Inc. | -2.09 USD | -206916.268% |
| Larimar Therapeutics, Inc. | -0.84 USD | -514976.19% |
| Mersana Therapeutics, Inc. | -1.48 USD | -292240.541% |
| Structure Therapeutics Inc. | -2.44 USD | -177221.311% |
| 89bio, Inc. | -2.00 USD | -216232.0% |
| Kezar Life Sciences, Inc. | -1.40 USD | -308945.714% |
| aTyr Pharma, Inc. | -0.94 USD | -460180.851% |
| Aligos Therapeutics, Inc. | -3.52 USD | -122815.909% |
| Viridian Therapeutics, Inc. | -5.31 USD | -81380.979% |
| EyeGate Pharmaceuticals, Inc. | -2.54 USD | -170240.157% |
| Akari Therapeutics, Plc | -2.04 USD | -211990.196% |
| Tevogen Bio Holdings Inc. | -0.00 USD | -1081659900.0% |
| Halozyme Therapeutics, Inc. | 2.13 USD | 203228.638% |
| Lexicon Pharmaceuticals, Inc. | -0.80 USD | -540730.0% |
| Liquidia Corporation | -1.21 USD | -357473.554% |
| Entera Bio Ltd. | -0.31 USD | -1395590.323% |
| GH Research PLC | -0.68 USD | -636170.588% |
| Vericel Corporation | -0.07 USD | -6467224.365% |
| Arbutus Biopharma Corporation | -0.44 USD | -983227.273% |
| Xencor, Inc. | -2.08 USD | -207911.538% |
| 60 Degrees Pharmaceuticals, Inc. | -0.95 USD | -455335.789% |
| Pasithea Therapeutics Corp. | -12.65 USD | -34102.688% |
| Coeptis Therapeutics Holdings, Inc. | -0.83 USD | -521181.928% |
| Vaxcyte, Inc. | -4.14 USD | -104408.213% |
| Xenon Pharmaceuticals Inc. | -2.73 USD | -158384.982% |
| Vanda Pharmaceuticals Inc. | 0.04 USD | 9900878.032% |
| Lexaria Bioscience Corp. | -1.01 USD | -428280.198% |
| Portage Biotech Inc. | -3.70 USD | -116836.216% |
| Cardio Diagnostics Holdings, Inc. | -0.66 USD | -655451.515% |
| Olema Pharmaceuticals, Inc. | -2.14 USD | -202079.439% |
| OncoCyte Corporation | -3.75 USD | -115277.067% |
| Qualigen Therapeutics, Inc. | -2.46 USD | -175779.675% |
| Processa Pharmaceuticals, Inc. | -8.48 USD | -50921.698% |
| Purple Biotech Ltd. | -0.09 USD | -4817984.633% |
| Tempest Therapeutics, Inc. | -1.91 USD | -226425.654% |
| Sol-Gel Technologies Ltd. | -1.01 USD | -428280.198% |
| Rhythm Pharmaceuticals, Inc. | -3.20 USD | -135107.5% |
| CollPlant Biotechnologies Ltd. | -0.62 USD | -697745.161% |
| Moleculin Biotech, Inc. | -15.07 USD | -28610.285% |
| United Therapeutics Corporation | 21.04 USD | 20663.878% |
| HilleVax, Inc. | -3.04 USD | -142223.684% |
| Silo Pharma, Inc. | -1.20 USD | -360453.333% |
| Telomir Pharmaceuticals, Inc. Common Stock | -0.44 USD | -983227.273% |
| Pharming Group N.V. | -0.16 USD | -2704050.0% |
| Tharimmune, Inc. | -107.08 USD | -3940.568% |
| Genprex, Inc. | -22.58 USD | -19061.382% |
| Apogee Therapeutics, Inc. | -0.00 USD | -127254017.647% |
| Neumora Therapeutics, Inc. Common Stock | -1.49 USD | -290278.523% |
| Pyxis Oncology, Inc. | -1.85 USD | -233772.432% |
| XTL Biopharmaceuticals Ltd. | -0.00 USD | -131110203.03% |
| Virios Therapeutics, Inc. | -0.28 USD | -1545128.571% |
| OKYO Pharma Limited | -0.00 USD | -721106566.667% |
| Savara Inc. | -0.33 USD | -1311003.03% |
| Windtree Therapeutics, Inc. | -92.23 USD | -4591.142% |
| Curis, Inc. | -8.96 USD | -48188.393% |
| Carmell Therapeutics Corporation | -1.46 USD | -296245.205% |
| Achieve Life Sciences, Inc. | -1.50 USD | -288342.667% |
| BeiGene, Ltd. | -8.45 USD | -51102.84% |
| Protagonist Therapeutics, Inc. | -1.39 USD | -311169.065% |
| Erasca, Inc. | -0.83 USD | -521181.928% |
| Protagenic Therapeutics, Inc. | -1.15 USD | -376129.565% |
| Protagenic Therapeutics, Inc. | -1.15 USD | -376129.565% |
| Vincerx Pharma, Inc. | -1.89 USD | -228822.751% |
| Fresh Tracks Therapeutics, Inc. | -0.96 USD | -450591.667% |
| Acrivon Therapeutics, Inc. Common Stock | -2.74 USD | -157806.569% |
| Celldex Therapeutics, Inc. | -2.92 USD | -148072.603% |
| Cogent Biosciences, Inc. | -2.42 USD | -178686.777% |
| Adicet Bio, Inc. | -3.31 USD | -130614.199% |
| Amicus Therapeutics, Inc. | -0.51 USD | -848260.784% |
| Adagene Inc. | -0.44 USD | -983227.273% |
| Estrella Immunopharma, Inc. | -0.21 USD | -2060204.762% |
| Quantum-Si incorporated | -0.68 USD | -636170.588% |
| Acurx Pharmaceuticals, Inc. | -1.15 USD | -376129.565% |
| Voyager Therapeutics, Inc. | 3.08 USD | 140575.325% |
| Compugen Ltd. | -0.21 USD | -2060204.762% |
| Generation Bio Co. | -1.96 USD | -220646.939% |
| Astria Therapeutics, Inc. | -2.42 USD | -178686.777% |
| Black Diamond Therapeutics, Inc. | -1.88 USD | -230040.426% |
| Invivyd, Inc. | -1.81 USD | -238940.884% |
| Relay Therapeutics, Inc. | -2.79 USD | -154976.703% |
| Quoin Pharmaceuticals, Ltd. | -9.64 USD | -44782.158% |
| Spero Therapeutics, Inc. | 0.43 USD | 1006295.349% |
| Artelo Biosciences, Inc. | -3.49 USD | -123872.493% |
| 2seventy bio, Inc. | -4.42 USD | -97787.783% |
| Instil Bio, Inc. | -24.00 USD | -17927.667% |
| Capricor Therapeutics, Inc. | -0.83 USD | -521181.928% |
| Elevai Labs, Inc. Common Stock | -0.40 USD | -1081560.0% |
| GeoVax Labs, Inc. | -10.22 USD | -42235.029% |
| Citius Pharmaceuticals, Inc. | -0.22 USD | -1966554.545% |
| Relmada Therapeutics, Inc. | -3.28 USD | -131809.756% |
| ALX Oncology Holdings Inc. | -3.74 USD | -115585.561% |
| Vir Biotechnology, Inc. | -4.59 USD | -94162.309% |
| Evaxion Biotech A/S | -8.11 USD | -53249.445% |
| Ocular Therapeutix, Inc. | -1.09 USD | -396839.45% |
| Verve Therapeutics, Inc. | -3.12 USD | -138574.359% |
| Tyra Biosciences, Inc. | -1.62 USD | -266976.543% |
| Cingulate Inc. | -311.99 USD | -1286.788% |
| Galmed Pharmaceuticals Ltd. | -30.05 USD | -14298.136% |
| Unity Biotechnology, Inc. | -2.70 USD | -160145.926% |
| Connect Biopharma Holdings Limited | -1.08 USD | -400514.815% |
| Clearmind Medicine Inc. | -59.18 USD | -7210.983% |
| Bolt Biotherapeutics, Inc. | -1.83 USD | -236328.415% |
| CERo Therapeutics Holdings, Inc. | -0.39 USD | -1109294.872% |
| Viking Therapeutics, Inc. | -0.91 USD | -475354.945% |
| Madrigal Pharmaceuticals, Inc. | -19.99 USD | -21544.022% |
| ImmunityBio, Inc. | -1.15 USD | -376129.565% |
| Korro Bio, Inc. | -53.08 USD | -8051.168% |
| Kineta, Inc. | -1.28 USD | -337918.75% |
| BioVie Inc. | -7.30 USD | -59169.041% |
| Codexis, Inc. | -1.12 USD | -386207.143% |
| Celularity Inc. | -11.02 USD | -39161.706% |
| Aileron Therapeutics, Inc. | -3.42 USD | -126409.942% |
| Crinetics Pharmaceuticals, Inc. | -3.69 USD | -117153.117% |
| Virax Biolabs Group Limited | -3.36 USD | -128669.048% |
| Cibus, Inc. | -25.95 USD | -16572.987% |
| IN8bio, Inc. | -1.00 USD | -432564.0% |
| Adverum Biotechnologies, Inc. | -11.62 USD | -37134.423% |
| Avalo Therapeutics, Inc. | -113.58 USD | -3709.333% |
| Ionis Pharmaceuticals, Inc. | -2.56 USD | -168909.375% |
| Eyenovia, Inc. | -0.66 USD | -655451.515% |
| Puma Biotechnology, Inc. | 0.46 USD | 940673.913% |
| Conduit Pharmaceuticals Inc. | -0.09 USD | -4786006.195% |
| Elevation Oncology, Inc. | -1.34 USD | -322783.582% |
| Xilio Therapeutics, Inc. | -2.78 USD | -155534.532% |
| Cardiff Oncology, Inc. | -0.93 USD | -465130.108% |
| Enanta Pharmaceuticals, Inc. | -6.38 USD | -67715.674% |
| Regulus Therapeutics Inc. | -1.58 USD | -273737.975% |
| Moolec Science SA | -1.50 USD | -288342.667% |
| Acumen Pharmaceuticals, Inc. | -1.08 USD | -400514.815% |
| LAVA Therapeutics N.V. | -1.57 USD | -275482.166% |
| Atea Pharmaceuticals, Inc. | -1.63 USD | -265338.037% |
| Compass Therapeutics, Inc. | -0.33 USD | -1311003.03% |
| Greenwich LifeSciences, Inc. | -0.69 USD | -626949.275% |
| TFF Pharmaceuticals, Inc. | -11.85 USD | -36411.73% |
| Humacyte, Inc. | -1.07 USD | -404258.879% |
| PMV Pharmaceuticals, Inc. | -1.44 USD | -300361.111% |
| Avenue Therapeutics, Inc. | -73.60 USD | -5778.587% |
| Genelux Corporation | -1.16 USD | -372886.207% |
| Trevi Therapeutics, Inc. | -0.29 USD | -1491844.828% |
| Notable Labs, Ltd. | -5.03 USD | -85916.7% |
| Immunovant, Inc. | -1.88 USD | -230040.426% |
| Quantum-Si incorporated | -0.68 USD | -636170.588% |
| DiaMedica Therapeutics Inc. | -0.60 USD | -721006.667% |
| Vera Therapeutics, Inc. | -2.25 USD | -192195.111% |
| Acasti Pharma Inc. | -1.35 USD | -320391.852% |
| MiNK Therapeutics, Inc. | -0.65 USD | -665536.923% |
| Soleno Therapeutics, Inc. | -2.36 USD | -183232.203% |
| PepGen Inc. | -3.30 USD | -131010.303% |
| Nuvectis Pharma, Inc. | -1.43 USD | -302462.238% |
| BriaCell Therapeutics Corp. | -0.29 USD | -1491844.828% |
| Immuneering Corporation | -1.88 USD | -230040.426% |
| Lixte Biotechnology Holdings, Inc. | -2.66 USD | -162555.639% |
| Belite Bio, Inc | -1.19 USD | -363483.193% |
| XOMA Corporation | -4.04 USD | -106995.05% |
| ARS Pharmaceuticals, Inc. | -0.57 USD | -758959.649% |
| Bionomics Limited | -1.02 USD | -424080.392% |
| Alpha Tau Medical Ltd. | -0.42 USD | -1030052.381% |
| uniQure N.V. | -6.47 USD | -66772.334% |
| Estrella Immunopharma, Inc. | -0.21 USD | -2060204.762% |
| Poseida Therapeutics, Inc. | -1.37 USD | -315713.139% |
| Forte Biosciences, Inc. | -24.92 USD | -17262.119% |
| Anebulo Pharmaceuticals, Inc. | -0.32 USD | -1351975.0% |
| Enlivex Therapeutics Ltd. | -1.56 USD | -277248.718% |
| Conduit Pharmaceuticals Inc. | -0.09 USD | -4786006.195% |
| SeaStar Medical Holding Corporation | -30.29 USD | -14184.054% |
| FibroBiologics, Inc. Common Stock | -0.59 USD | -733228.814% |
| Altimmune, Inc. | -1.66 USD | -260540.964% |
| LENZ Therapeutics, Inc. | -15.30 USD | -28178.693% |
| Alpha Tau Medical Ltd. | -0.42 USD | -1030052.381% |
| Peak Bio, Inc. | - USD | Infinity% |
| Zevra Therapeutics, Inc. | -1.30 USD | -332718.462% |
| Benitec Biopharma Inc. | -5.36 USD | -80620.896% |
| Spyre Therapeutics, Inc. | -49.12 USD | -8708.306% |
| NKGen Biotech, Inc. Common Stock | -5.38 USD | -80320.818% |
| Zura Bio Limited | -2.09 USD | -206916.268% |
| PolyPid Ltd. | -16.99 USD | -25365.803% |
| NKGen Biotech, Inc. Warrants | -5.38 USD | -80320.818% |
| argenx SE | -5.16 USD | -83749.612% |
| Immunome, Inc. | -5.38 USD | -80320.818% |
| Verona Pharma plc | -0.54 USD | -801129.63% |
| enGene Holdings Inc. Warrants | -4.51 USD | -95834.368% |
| Shattuck Labs, Inc. | -2.05 USD | -210955.61% |
| CervoMed Inc. | -0.82 USD | -527539.024% |
| Plus Therapeutics, Inc. | -4.24 USD | -101943.396% |
| Dianthus Therapeutics, Inc. | -8.45 USD | -51102.84% |
| Moolec Science SA | -1.50 USD | -288342.667% |
| Enveric Biosciences, Inc. | -8.09 USD | -53381.335% |
| Design Therapeutics, Inc. | -1.19 USD | -363483.193% |
| Leap Therapeutics, Inc. | -3.98 USD | -108609.548% |
| Seelos Therapeutics, Inc. | -7.73 USD | -55872.057% |
| Achilles Therapeutics plc | -1.74 USD | -248557.471% |
| CERo Therapeutics Holdings, Inc. | -0.39 USD | -1109294.872% |
| CG Oncology, Inc. Common stock | -15.65 USD | -27546.262% |
| Fractyl Health, Inc. Common Stock | -1.98 USD | -218417.172% |
| Rani Therapeutics Holdings, Inc. | -1.33 USD | -325211.278% |
| MoonLake Immunotherapeutics | -0.73 USD | -592590.411% |
| Tourmaline Bio, Inc. | -8.87 USD | -48678.354% |
| Beam Therapeutics Inc. | -1.72 USD | -251448.837% |
| Mirum Pharmaceuticals, Inc. | -4.00 USD | -108066.0% |
| AEON Biopharma, Inc. | - USD | Infinity% |
| Aadi Bioscience, Inc. | -2.44 USD | -177221.311% |
| Enliven Therapeutics, Inc. | -2.01 USD | -215155.721% |
| Kiora Pharmaceuticals, Inc. | -24.25 USD | -17741.814% |
| NeurAxis, Inc. | -4.03 USD | -107260.794% |
| Iovance Biotherapeutics, Inc. | -1.89 USD | -228822.751% |
| Lumos Pharma, Inc. | -4.18 USD | -103408.134% |
| Opiant Pharmaceuticals, Inc. | 0.68 USD | 636370.588% |
| Palisade Bio, Inc. | -27.01 USD | -15918.66% |
| Nutriband Inc. | -0.69 USD | -626949.275% |
| Taysha Gene Therapies, Inc. | -0.96 USD | -450591.667% |
| Neurogene Inc. | -2.83 USD | -152784.806% |
| Kintara Therapeutics, Inc. | -3.23 USD | -133851.703% |
| CARGO Therapeutics, Inc. Common Stock | -2.38 USD | -181691.597% |
| Athira Pharma, Inc. | -3.10 USD | -139469.032% |
| HCW Biologics Inc. | -0.70 USD | -617991.429% |
| XOMA Corporation | -4.04 USD | -106995.05% |
| Nektar Therapeutics | -1.45 USD | -298288.966% |
| Arvinas, Inc. | -6.62 USD | -65257.1% |
| Tevogen Bio Holdings Inc. | -0.00 USD | -1081659900.0% |
| Merus N.V. | -3.00 USD | -144121.333% |
| Omega Therapeutics, Inc. | -1.80 USD | -240268.889% |
| Quince Therapeutics, Inc. | -0.84 USD | -514976.19% |
| Rezolute, Inc. | -1.33 USD | -325211.278% |
| Clene Inc. | -9.43 USD | -45781.654% |
| Indaptus Therapeutics, Inc. | -1.84 USD | -235043.478% |
| BeyondSpring Inc. | -0.54 USD | -801129.63% |
| Synlogic, Inc. | -8.81 USD | -49010.556% |
| Allarity Therapeutics, Inc. | -0.01 USD | -42006113.592% |
| Phio Pharmaceuticals Corp. | -46.87 USD | -9131.15% |
| Peak Bio, Inc. | - USD | Infinity% |
| Werewolf Therapeutics, Inc. | -1.05 USD | -411960.952% |
| Krystal Biotech, Inc. | 0.40 USD | 1081760.0% |
| Karyopharm Therapeutics Inc. | -1.25 USD | -346031.2% |
| SpringWorks Therapeutics, Inc. | -5.15 USD | -83912.427% |
| Lipella Pharmaceuticals Inc. | -0.77 USD | -561801.299% |
| MannKind Corporation | -0.04 USD | -9679184.116% |
| Ikena Oncology, Inc. | -1.63 USD | -265338.037% |
| Cyclerion Therapeutics, Inc. | -8.99 USD | -48027.253% |
| Gyre Therapeutics, Inc. | -1.41 USD | -306753.901% |
| Gossamer Bio, Inc. | -1.18 USD | -366564.407% |
| CohBar, Inc. | -4.13 USD | -104661.259% |
| Cognition Therapeutics, Inc. | -0.86 USD | -502997.674% |
| NRx Pharmaceuticals, Inc. | -3.98 USD | -108609.548% |
| Legend Biotech Corporation | -2.94 USD | -147064.626% |
| Mural Oncology plc | -12.43 USD | -34708.045% |
| Disc Medicine, Inc. | -3.43 USD | -126041.108% |
| Champions Oncology, Inc. | -0.54 USD | -801129.63% |
| REGENXBIO Inc. | -6.02 USD | -71771.096% |
| Ensysce Biosciences, Inc. | -4.69 USD | -92152.452% |
| Anavex Life Sciences Corp. | -0.60 USD | -721006.667% |
| Cellectar Biosciences, Inc. | -3.11 USD | -139020.257% |
| Edgewise Therapeutics, Inc. | -1.57 USD | -275482.166% |
| Vaxart, Inc. | -0.57 USD | -758959.649% |
| PharmaCyte Biotech, Inc. | -1.80 USD | -240268.889% |
| Aldeyra Therapeutics, Inc. | -0.64 USD | -675937.5% |
| Cellectis S.A. | -1.77 USD | -244342.938% |
| Longeveron Inc. | -10.22 USD | -42235.029% |
| Repare Therapeutics Inc. | -2.23 USD | -193919.731% |
| Sarepta Therapeutics, Inc. | -5.80 USD | -74497.241% |
| Inozyme Pharma, Inc. | -1.37 USD | -315713.139% |
| Revolution Medicines, Inc. | -3.86 USD | -111989.119% |
| Nymox Pharmaceutical Corporation | -0.07 USD | -5886485.034% |
| Third Harmonic Bio, Inc. | -0.78 USD | -554597.436% |
| ArriVent BioPharma, Inc. Common Stock | -2.17 USD | -199284.332% |
| AN2 Therapeutics, Inc. | -2.74 USD | -157806.569% |
| Anixa Biosciences, Inc. | -0.32 USD | -1351975.0% |
| Vertex Pharmaceuticals Incorporated | 14.05 USD | 30894.591% |
| Denali Therapeutics Inc. | -1.06 USD | -408073.585% |
| Revelation Biosciences, Inc. | -0.53 USD | -816247.17% |
| Veru Inc. | -1.10 USD | -393230.909% |
| Corvus Pharmaceuticals, Inc. | -0.56 USD | -772514.286% |
| Cingulate Inc. | -311.99 USD | -1286.788% |
| Passage Bio, Inc. | -1.86 USD | -232515.054% |
| Context Therapeutics Inc. | -1.50 USD | -288342.667% |
| Exicure, Inc. | -2.11 USD | -204954.028% |
| Day One Biopharmaceuticals, Inc. | -2.37 USD | -182458.65% |
| Oramed Pharmaceuticals Inc. | -0.97 USD | -445945.361% |
| Scinai Immunotherapeutics Ltd. | -16.62 USD | -25932.732% |
| Nuvalent, Inc. | -2.17 USD | -199284.332% |
| ABVC BioPharma, Inc. | -2.43 USD | -177951.029% |
| Carisma Therapeutics, Inc. | -2.59 USD | -166951.737% |
| Unicycive Therapeutics, Inc. | -1.28 USD | -337918.75% |
| OmniAb, Inc. | -0.51 USD | -848260.784% |
| Anew Medical, Inc. | 0.14 USD | 3090557.143% |
| Fennec Pharmaceuticals Inc. | -0.60 USD | -721006.667% |
| Lipocine Inc. | -3.14 USD | -137691.083% |
| Lexeo Therapeutics, Inc. Common Stock | -2.49 USD | -173660.643% |
| Nautilus Biotechnology, Inc. | -0.51 USD | -848260.784% |
| SAB Biotherapeutics, Inc. | -7.64 USD | -56531.414% |
| G1 Therapeutics, Inc. | -0.93 USD | -465130.108% |
| Bellerophon Therapeutics, Inc. | -2.08 USD | -207911.538% |
| Sage Therapeutics, Inc. | -9.05 USD | -47708.177% |
| Ocugen, Inc. | -0.26 USD | -1663992.308% |
| Mind Medicine (MindMed) Inc. | -2.44 USD | -177221.311% |
| Q32 Bio Inc. | -35.16 USD | -12205.575% |
| Brainstorm Cell Therapeutics Inc. | -0.40 USD | -1081560.0% |
| Alumis Inc. Common Stock | -2.99 USD | -144603.679% |
| Equillium, Inc. | -0.38 USD | -1138489.474% |
| Kyverna Therapeutics, Inc. | -0.00 USD | -4326639900.0% |
| Coya Therapeutics, Inc. | -0.79 USD | -547575.949% |
| CNS Pharmaceuticals, Inc. | -251.35 USD | -1621.361% |
| Dominari Holdings Inc. | -4.38 USD | -98681.735% |
| Edesa Biotech, Inc. | -2.93 USD | -147566.894% |
| vTv Therapeutics Inc. | -9.71 USD | -44458.599% |
| Bio-Techne Corporation | 1.07 USD | 404458.879% |
| Agios Pharmaceuticals, Inc. | -6.33 USD | -68251.343% |
| Harmony Biosciences Holdings, Inc. | 2.17 USD | 199484.332% |
| Prelude Therapeutics Incorporated | -2.02 USD | -214090.099% |
| Candel Therapeutics, Inc. | -1.31 USD | -330177.863% |
| iTeos Therapeutics, Inc. | -3.15 USD | -137253.651% |
| Nkarta, Inc. | -2.40 USD | -180176.667% |
| BioCardia, Inc. | -8.19 USD | -52728.327% |
| Iterum Therapeutics plc | -2.96 USD | -146070.27% |